SciSparc Ltd. – Filings and Transcripts

NASDAQ: SPRC
Share price (11/9/26): $0.42
Market cap (11/9/26): $855 thousand

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Shelf registration

Shelf registration – amended

Shelf registration

Shelf registration

Registration of securities for employees

Ownership Filter

News Filter

Material disclosure – amended

Material disclosure

To: Holder of Certain Existing Warrants to Purchase Ordinary Shares Issued in February 2026 Re: Inducement Offer to Exercise Existing Warrants to Purchase Ordinary Shares Issued in February 2026 Dear Holder

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916 Israel

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness